Hepatitis b and Pathogen resistance

Summary:

Pathogen resistance is found among people with Hepatitis b, especially for people who are male, 50-59 old.

The study analyzes which people have Pathogen resistance with Hepatitis b. It is created by eHealthMe based on reports of 201 people who have Hepatitis b from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hepatitis b?

Hepatitis b is found to be associated with 519 drugs and 683 conditions by eHealthMe. Check the latest studies of Hepatitis b.

What is Pathogen resistance?

Pathogen resistance is found to be associated with 443 drugs and 596 conditions by eHealthMe. Check the latest studies of Pathogen resistance.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 25, 2026

201 people who have Hepatitis B and Pathogen Resistance are studied.

Would you have Pathogen resistance when you have Hepatitis b?

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Pathogen resistance?

- Check whether Pathogen resistance is associated with a drug or a condition

Related studies:

Treatments, associated drugs and conditions:

Hepatitis b (21,088 reports)
Pathogen resistance (9,788 reports)

All the drugs that are associated with Pathogen resistance:

Pathogen resistance (443 drugs)

All the conditions that are associated with Pathogen resistance:

Pathogen resistance (596 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Pathogen resistance and Hepatitis b, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.